Gray Matter Deterioration Pattern During Alzheimer's Disease Progression: A Regions-of-Interest Based Surface Morphometry Study

Abstract

Accurate detection of the regions of Alzheimer's disease (AD) lesions is critical for early intervention to effectively slow down the progression of the disease. Although gray matter volumetric abnormalities are commonly detected in patients with mild cognition impairment (MCI) and patients with AD, the gray matter surface-based deterioration pattern associated with the progression of the disease from MCI to AD stages is largely unknown. To identify group differences in gray matter surface morphometry, including cortical thickness, the gyrification index (GI), and the sulcus depth, 80 subjects from the Alzheimer's Disease Neuroimaging Initiative (ADNI) database were split into healthy controls (HCs; N = 20), early MCIs (EMCI; N = 20), late MCIs (LMCI; N = 20), and ADs (N = 20). Regions-of-interest (ROI)-based surface morphometry was subsequently studied and compared across the four stage groups to characterize the gray matter deterioration during AD progression. Co-alteration patterns (Spearman's correlation coefficient) across the whole brain were also examined. Results showed that patients with MCI and AD exhibited a significant reduction in cortical thickness (p < 0.001) mainly in the cingulate region (four subregions) and in the temporal (thirteen subregions), parietal (five subregions), and frontal (six subregions) lobes compared to HCs. The sulcus depth of the eight temporal, four frontal, four occipital, and eight parietal subregions were also significantly affected (p < 0.001) by the progression of AD. The GI was shown to be insensitive to AD progression (only three subregions were detected with a significant difference, p < 0.001). Moreover, Spearman's correlation analysis confirmed that the co-alteration pattern of the cortical thickness and sulcus depth indices is predominant during AD progression. The findings highlight the relevance between gray matter surface morphometry and the stages of AD, laying the foundation for in vivo tracking of AD progression. The co-alteration pattern of surface-based morphometry would improve the researchers' knowledge of the underlying pathologic mechanisms in AD.

Structural brain changes in patients with persistent headache after COVID-19 resolution

“…With regard to the extent of the identified WM changes, according to the effect size (Cohen's d values), these changes were mild or moderate. Despite this modest magnitude, the trend of these changes is consistent with common findings in the neuroimage literature regarding changes detected in a wide range of pathologies, such as schizophrenia [50][51][52], Alzheimer's disease [53][54][55], Parkinson's disease [56][57][58], or migraine [11,12,18]. In these disorders, lower FA values and higher MD, RD or AD have been identified in the patient groups compared to healthy controls.…”

Microglial Activation, Tau Pathology, and Neurodegeneration Biomarkers Predict Longitudinal Cognitive Decline in Alzheimer’s Disease Continuum

“…These results coincided with several previous studies. A recent study showed that the cortical thickness and sulcus depth indices were significantly changed during AD progression, suggesting that gray matter characteristics can track AD progression ( Wu et al, 2021 ). Similarly, another study demonstrated distinct patterns of gray matter atrophy associated with mild behavioral impairment in CN subjects ( Shu et al, 2021 ).…”

Modulation of Brain Activity and Functional Connectivity by Acupuncture Combined With Donepezil on Mild-to-Moderate Alzheimer's Disease: A Neuroimaging Pilot Study

“…These brain regions are at the center of many brain function networks and are closely related to the progression of AD ( 22 ). As the condition develops, the functional connectivity of the above brain areas is gradually weakened ( 23 ).…”